Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance

• Published in: Nutrients 2023-04, Vol.15 (9), p.2105
• Main Authors: Paublini, Hernán, López González, Angel Arturo, Busquets-Cortés, Carla, Tomas-Gil, Pilar, Riutord-Sbert, Pere, Ramírez-Manent, José Ignacio
• Format: Article
• Language: English
• Subjects: Abdomen; Adipose tissue; Adipose tissues; Arteriosclerosis; atherogenic dyslipidaemia; atherogenic risk; Atherosclerosis; Atherosclerosis - epidemiology; Atherosclerosis - etiology; Cholesterol; Cross-Sectional Studies; Developing countries; Diabetes; Dyslipidemias - epidemiology; Fatty acids; Fatty Acids, Nonesterified; Food; Glucose; Health aspects; High density lipoprotein; Humans; Hypercholesterolemia; Insulin; Insulin Resistance; lipid triad; Lipids; Lipoproteins; Liver; Low density lipoprotein; Low density lipoproteins; Metabolic disorders; Metabolic syndrome; Morbidity; Mortality; Multivariate analysis; Obesity; Occupational health; Professional ethics; Regression analysis; Risk assessment; Social classes; Statistical analysis; Trans fatty acids; Triglycerides; Type 2 diabetes; Womens health
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15092105

Atherogenic dyslipidaemia (AD) and lipid triad (LT) are characterised by high triglyceride levels together with low HDL and normal or high LDL cholesterol and are favoured by a persistent state of insulin resistance (IR), which increases the release of free fatty acids from abdominal adipose tissue. This alteration in the lipid profile favours the accelerated development of atherosclerosis, which is the most important cause of morbidity and mortality in all countries in the developed and developing world. One of the elements that plays a major role in the genesis of AD is IR. The aim of this study was to determine the relationship between variables that assess atherogenic risk (AD and LT) and scales that assess the risk of presenting insulin resistance. A descriptive cross-sectional study of 418,343 workers was conducted to evaluate atherogenic dyslipidaemia and lipid triad; a relationship with three insulin resistance risk scales (Triglycerides/HDL, TyG index, METS-IR) was established. The usefulness of IR risk scales for predicting AD and LT was calculated by applying ROC curves, obtaining the area under the curve (AUC) and cut-off points with their sensitivity, specificity, and Youden index. Multivariate analysis was performed by binary logistic regression. The prevalence of high-risk values for insulin resistance with all of the scales is much higher in people with AD and LT compared to those without. The ROC curves present us with an AUC with the three insulin resistance risk scales for the two dyslipidaemias studied with figures ranging between 0.856 and 0.991, which implies that the results are good/very good. A relationship between atherogenic dyslipidaemia and the three insulin resistance risk scales assessed is revealed, with higher IR mean values and prevalence in people with atherogenic dyslipidaemia and lipid triad. The three scales make it possible to adequately classify the presence of AD and LT. The highest AUC is presented by the triglycerides/HDL scale, with a result close to 1. METS-IR is the most recommended formula to estimate insulin resistance.